Reactive oxygen species (ROS) are well known to be involved in oncogene-mediated cellular transformation. However, the regulatory mechanisms underlying ROS generation in oncogene-transformed cells are unclear. In the present study, we found that oncogenic K-Ras induces ROS generation through activation of NADPH oxidase 1 (NOX1), which is a critical regulator for the K-Ras-induced cellular transformation. NOX1 was activated by K-Ras-dependent translocation of p47 phox , a subunit of NOX1 to plasma membrane. Of note, PKCd, when it was activated by PDPK1, directly bound to the SH3-N domain of p47 phox and catalyzed the phosphorylation on Ser348 and Ser473 residues of p47 phox C-terminal in a K-Ras-dependent manner, finally leading to its membrane translocation. Notably, oncogenic K-Ras activated all MAPKs (JNK, ERK and p38); however, only p38 was involved in p47 phox -NOX1-dependent ROS generation and consequent transformation. Importantly, K-Ras-induced activation of p38 led to an activation of PDPK1, which then signals through PKCd, p47 phox and NOX1. In agreement with the mechanism, inhibition of p38, PDPK1, PKCd, p47 phox or NOX1 effectively blocked K-Ras-induced ROS generation, anchorage-independent colony formation and tumor formation. Taken together, our findings demonstrated that oncogenic K-Ras activates the signaling cascade p38/ PDPK1/PKCd/p47 phox /NOX1 for ROS generation and consequent malignant cellular transformation.
Many studies have suggested that reactive oxygen species (ROS) are not merely harmful by-products but also serve as signaling molecules involved in many cellular pathways such as growth factor signaling, 1,2 inflammatory response 3 and apoptosis. 4 Consistent with this view, intracellular ROS are generated purposely by plasma membrane-bound nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complexes. 5 As ROS displays both beneficial as a signaling molecule and harmful effects as oxidative byproducts, the pathways that regulate ROS homeostasis may be crucial in cellular function. Aberrantly increased intracellular ROS has been often implicated in a large number of diseases including atherosclerosis, pulmonary fibrosis, cancer, neurodegenerative diseases and aging. [6] [7] [8] In cancers, as highly reactive molecules, ROS act as mutagenic and may thereby promote cancers. Also, ROS promote cancer progression by participating in oncogenic signaling pathways such as Ras, c-Myc and c-Src. [9] [10] [11] Indeed, Ras-induced ROS generation caused to increase the activation of mitogen-activated protein kinase (MAPK) and DNA-binding activities of the transcription factors such as activator protein-1, activator protein-2 and nuclear factor-kB in rat kidney epithelial cells, 12 suggesting that ROS participate in cell signaling.
GTPases of the Ras family of oncogenes transduce extracellular signals to the nucleus, acting as molecular switches in signaling networks that connect a variety of upstream signals to a wide array of downstream signaling pathways. Ras mutations are found in around 30% of all human malignancies, with K-Ras being the most frequently activated oncogene in cancer cells. 13, 14 Notably, aberrant activation of Ras alone was found to be sufficient to transform mammary epithelial cells into malignant cells. Although the underlying mechanisms remain obscure, several lines of evidence suggested the functional role of ROS in Ras-induced cellular transformation. 12, [15] [16] [17] In the previous study, constitutive expression of the active form of v-Ha-Ras caused cellular transformation, accompanying with ROS generation; however, overexpression of antioxidant enzymes such as manganese-containing superoxide dismutase or copper-and zinc-containing superoxide dismutase effectively inhibited Ras-induced transformation, 12, 16 indicating that Ras induces cellular transformation through ROS production. In line with these studies, in human lung adenocarcinoma cells, the activity of K-Ras was correlated positively with the levels of ROS. 18 In lung epithelial cells, oncogenic K-Ras expression promoted ROS generation through cyclooxygenase (COX)-2, causing DNA damages and malignant transformation.
Although mitochondrial ROS production was suggested to be important for Ras-driven malignant transformation, 20 Ras increased ROS through NADPH oxidase 1 (NOX1) that is a plasma membrane-bound enzyme, finally causing malignant transformation. 21 However, the precise molecular mechanisms underlying K-Ras-induced ROS generation remain largely unknown.
In the present study, we demonstrate that K-Ras-induced ROS generation in normal fibroblasts is mediated by NOX1/ p47
phox . Also, we show that only p38 among all MAPKs is involved in K-Ras-induced ROS generation and consequent cellular transformation. Importantly, K-Ras-induced activation of p38 led to an activation of PDPK1, which then signals through PKCd, p47 phox and NOX1. In addition, we provide an evidence that the same signaling pathway is also driven by endogenous oncogenic K-Ras in cancer cells. Collectively, our findings suggest that oncogenic K-Ras activates the signaling axis p38/PDPK1/PKCd/p47 phox /NOX1 for ROS generation and consequent cellular transformation.
Results

ROS is crucial for K-Ras
V12 -induced cellular transformation. We examined whether K-Ras generates ROS in normal fibroblasts. To this end, Rat2 fibroblasts were transduced with K-Ras V12 that is a constitutively active mutant form of the protein. Notably, K-Ras V12 caused to increase DCFDA fluorescence (Figure 1a ), indicating that intracellular ROS was increased in a time-dependent manner in K-Ras V12 -transduced cells, whereas low ROS levels were maintained in cells mock-transduced with a control vector, MFG (Figure 1a ; Supplementary Figures S1A and B) . Concomitant with ROS generation, K-Ras V12 -transduced cells acquired an anchorage-independent colony-forming phenotype (Supplementary Figure S1C) . However, ectopic expression of the potent antioxidant enzymes catalase or glutathione peroxidase blocked the K-Ras V12 -induced ROS generation ( Figure 1b ) and suppressed the formation of anchorage-independent colonies caused by K-Ras V12 ( Figure 1c ). To further elucidate whether ROS are associated with K-Ras V12 -induced tumorigenesis, we subcutaneously injected K-Ras V12 -transduced or non-transduced cells, with or without transfected catalase, into nude mice. K-Ras V12 -transduced cells efficiently formed tumors in nude mice compared with non-transduced cells. However, catalase expression effectively blocked K-Ras V12 -induced tumorigenesis in nude mice (Figure 1d ). Collectively, these results suggest that ROS has a key role in K-Ras V12 -induced transformation.
NOX1 and p47
phox are required for K-Ras-induced ROS generation. As non-phagocytic NADPH oxidases have been reported to contribute ROS generation in Rastransfected fibroblasts, 21 we treated cells with small interfering RNAs (siRNAs) against large catalytic subunits of NADPH oxidase (Nox1, Nox2, Nox3 and Nox4), and then transduced with K-Ras V12 (Supplementary Figure S2A) . Importantly, K-Ras V12 -induced ROS generation and anchorage-independent colony formation were suppressed by downregulation of Nox1, but not other Nox family members (Figures 2a and b) . Because K-Ras V12 -induced ROS generation could occur in mitochondria, we examined the possibility by treatment with rotenone, a mitochondrial ROS blocker. However, rotenone did not affect ROS generation (data not shown), indicating that mitochondrial mechanisms are not involved in K-Ras-induced ROS generation. As Nox1 activity is regulated by the cytosolic regulatory subunit p47 phox or its homolog NOXO1, 22, 23 cells were treated with siRNAs targeting p47 phox or NOXO1 (Supplementary Figure  S2B) . Downregulation of p47 phox inhibited K-Ras V12 -induced ROS generation and anchorage-independent colony formation, whereas siRNAs targeting NOXO1 did not (Figures 2c  and d) , suggesting that p47 phox has a crucial role in K-Ras V12 -induced activation of Nox1. Phosphorylation of p47 phox and its translocation to the plasma membrane have been shown to be key events for NADPH oxidase activation. 24 We therefore investigated whether K-Ras V12 induces phosphorylation and membrane translocation of p47 phox . To this end, we immunoprecipitated all phosphorylated proteins on serine, threonine or tyrosine residues. Importantly, p47
phox was detected only in immunoprecipitated proteins that are phosphorylated on serine residues, indicating that K-Ras V12 promotes phosphorylation of p47 phox at serine (Figure 2e ). Taken together, these results suggest that K-Ras V12 -induced ROS generation mainly occurs through a Nox1/p47 phox pathway.
K-Ras-dependent phosphorylation of p47 phox is mediated by PKCd and contributes to p47 phox translocation to the plasma membrane and ROS generation. Because PKC isozymes are involved in Ras-induced cellular transformation, 25 we examined the kinase activity of PKC isozymes in K-Ras V12 -transduced cells. Importantly, K-Ras V12 selectively increased the kinase activity of PKCd among the isozymes (Figure 3a) . Also, when cells were transfected with dominant-negative (DN) mutant forms of PKC isozymes, only DN-PKCd suppressed K-Ras V12 -induced ROS generation and anchorage-independent colony formation, whereas DN-PKCa and DN-PKCb had no effect on these phenotypes (Figures 3b and c) . In agreement, DNPKCd effectively suppressed K-Ras V12 -induced tumor formation in xenograft mice, (Figure 3d ). These results suggest that PKCd has a pivotal role in K-Ras V12 -induced ROS generation and cellular transformation.
As p47 phox was phosphorylated on the serine residue in a K-Ras V12 -dependent manner, we next assessed whether PKCd catalyzes the phosphorylation of p47 phox . To examine this possibility, cells were transfected with each DN PKC isoform and then transduced with K-Ras V12 . Notably, when cells are transfected with DN-PKCd, p47 phox was not detected in serine-phosphorylated proteins immunoprecipitated with an anti-phospho-serine antibody (Figure 3e ). Also, DN-PKCd attenuated K-Ras V12 -induced translocation of p47 phox to the membrane fraction, indicating that PKCd is responsible for the activation and translocation of p47 phox to membraneanchored NOX1. We next examined whether PKCd interacts directly with p47 phox by GST-p47 phox pull-down assays. Notably, PKCd was co-precipitated with GST-p47 phox -coupled glutathione-sepharose, indicating that PKCd interacts with p47 phox (Figure 3f ). To further examine the PKCd-mediated phosphorylation of p47 phox , we performed immune complex kinase assays using GST-p47 phox as a substrate. Importantly, PKCd phosphorylated GST-p47 phox , whereas PKCa and PKCb did not (Figure 3g ). Collectively, these results suggest that PKCd directly binds to and phosphorylates p47 phox in a K-Ras V12 -dependent manner.
PKCd-induced phosphorylation of Ser348 and Ser379 residues in p47 phox is critical for oncogenic K-Rasinduced ROS generation and cellular transformation. To find out the domain of p47 phox that interacts with PKCd, we cloned each domain of p47 phox that is phox homology (PX), N-and C-terminal SH3 (SH3-N, SH3-C) and polybasic/ proline-rich (PP) domains, as well as the full length of p47 phox into pGEX-2T, and purified the GST-fusion proteins for GST pull-down assays. Notably, PKCd was co-precipitated with GST-SH3-N as well as full-length GST-p47 phox in lysates of K-Ras V12 -transduced cells, but not with other domains (Figures 4a and b) . To confirm this result, we cloned FLAG-tagged full-length p47 phox into pFLAG-CMV2 and the HA-tagged domain of p47 phox (PX, SH3-N, SH3-C and PP) into pCMV-HA. Consistently, PKCd is co-immunoprecipitated with the SH3-N domain and fulllength p47 phox (Figures 4a and c) . These results suggest that PKCd interacts with the SH3-N domain of p47 phox in a K-Ras V12 -dependent manner. As PKCd interacts directly with p47 phox , we next examined which serine residues of p47 phox are phosphorylated by PKCd. To this end, we generated GST-fusion protein p47 phox harboring a point mutation (S345A, S348A, S359A, S370A, S379A, S348/379A and S345/359A) and compared them with wild type as substrates in PKCd kinase assays. Though PKCd phosphorylated the wild-type GST-p47 phox substrate in the kinase assay, it failed to phosphorylate p47 phox harboring point mutation S348A or/and S379A substitutions (Figure 4d ), indicating that PKCd phosphorylates Ser348 and Ser379 in p47 phox . To further confirm, we performed PKCd kinase assays in a cell-free system using recombinant, active PKCd. Consistently, recombinant PKCd displayed reduced catalytic activity toward the GST-S348A, GST-S379A and GST-S348/ 379A point-mutant forms of p47 phox compared with other mutants (Supplementary Figure S3) . These results suggest that PKCd phosphorylates Ser348 and Ser379 of p47 phox in a K-Ras V12 -dependent manner. We next examined whether Ser348 and/or Ser379 residues of p47 phox are critical for the interaction with PKCd and translocation of p47 phox to the plasma membrane. To this end, we cloned the HA-tagged p47 phox mutant forms HA-S345A, HA-S348A, HA-S359A, HA-S370A, HA-S379A, HA-S348/379A and HA-S345/359A, as well as wild-type HA-tagged p47 phox . After cells were transfected with these constructs and then transduced with K-Ras V12 , HA-tagged p47 phox was immunoprecipitated with an anti-HA antibody. Notably, PKCd was co-immunoprecipitated with all point-mutant forms of p47 phox , indicating that Ser348 and/or Ser379 residues are not critical for the interaction with PKCd ( Figure 4e) . Notably, however, HA-S348A, HA-S379A and HA-S348/379A pointmutant forms were not detected in the membrane fraction, whereas other mutant forms were. These results suggest that phosphorylation of p47 phox at Ser348 and Ser379 is crucial for its membrane translocation and activation of NOX1. In agreement, transfection with S348A, S379A or S348/379A mutant forms of p47 phox attenuated the K-Ras
V12
-induced ROS and anchorage-independent colony-forming ability (Figures 4f  and g ). Collectively, these results suggest that PKCd-mediated phosphorylation of p47 phox at Ser348 and Ser379 is crucial for K-Ras V12 -induced ROS generation and cellular transformation.
K-Ras-induced activation of p38 is required for ROS generation and cellular transformation. As oncogenic Ras is known to activate multiple downstream signaling including MAPK family members, 26, 27 we examined whether K-Ras V12 activates ERK, p38 and JNK. As expected, K-Ras V12 expression resulted in activation of all three MAPKs (Figure 5a ). Importantly, transfection with DN-p38 effectively suppressed K-Ras V12 -induced ROS generation, whereas DN-ERK or DN-JNK had no such effect (Figure 5b) . Consistently, treatment with the specific p38 inhibitor SB203580 decreased K-Ras V12 -induced ROS (Figure 5c ), indicating that p38 is a downstream effector of K-Ras V12 for ROS generation. In agreement, transfection with DN-p38 attenuated K-Ras V12 -induced anchorage-independent colony formation (Figure 5d ). Intriguingly, despite the fact that ERK was not involved in ROS generation, DN-ERK suppressed K-Ras V12 -induced colony formation, suggesting that ERK participates in K-Ras V12 -induced cellular transformation in a ROS-independent manner. To further confirm that p38 is a downstream effector of K-Ras V12 -induced cellular transformation, we subcutaneously inoculated cells that express both DN-p38 and K-Ras V12 into athymic nude mice, and monitored tumor formation. Notably, DN-p38 effectively attenuated K-Ras V12 -induced tumorigenesis in mice (Figure 5e ). Collectively, these results suggest that p38 has a pivotal role in K-Ras V12 -induced ROS generation and consequent cellular transformation.
To further elucidate the role of p38 in K-Ras V12 -induced malignant transformation, we examined whether p38 acts as an upstream signal of PKCd. To this end, we determined the amino acid of PKCd that is phosphorylated in a K-Ras V12 -dependent manner. By immunoprecipitation using antibodies against phospho-serine, phospho-threonine or phosphotyrosine residues, we found that PKCd is phosphorylated on Tyr and Thr residues in a K-Ras V12 -dependent manner (Supplementary Figure S4A) . In a further analysis, the kinase Figure S4C) . Supporting these results, several evidences suggested that the phosphorylation of PKCd on Thr505 is associated with kinase activity. Thus, we analyzed the phosphorylation status of PKCd on Thr505 after transfection with DN-p38. Notably, K-Ras V12 -induced phosphorylation of Thr505 in PKCd was blocked by DN-p38 (Figure 5f ). In line with this, DN-p38 displayed same effects that we observed when PKCd was inhibited, indicating that K-Ras V12 activates PKCd through p38 MAPK. DN-p38, but not DN-ERK or DN-JNK, decreased the interaction between p47 phox and PKCd (Figure 5g ). Also, DN-p38 inhibited K-Ras V12 -induced phosphorylation at serine residues of p47 phox (Figure 5h ). In agreement, transfection with wild-type p38 increased the interaction of p47 phox with PKCd, p47 phox phosphorylation and translocation to the plasma membrane; these effects were also observed in the presence of K-Ras V12 , albeit to a lesser extent (Figure 5i ). Overexpression of p38 also increased ROS generation, an effect that was greater in the absence than presence of K-Ras V12 (Figure 5j ). Collectively, these results suggest that K-Ras V12 activates the p38/PKCd/ p47 phox /NOX1 signaling axis for ROS generation. p38-mediated activation of PDPK1 is necessary for K-Ras V12 -induced PKCd/p47 phox signaling and subsequent ROS generation and cellular transformation. PDPK1 was first identified based on its ability to phosphorylate Thr308 of AKT. [30] [31] [32] However, conservation of aminoacid sequences similar to those surrounding Thr308 of AKT in the AGC family of Ser/Thr protein kinases suggested that PDPK1 may phosphorylate other AGC protein kinase family members, including PKC isoforms. In agreement with this, recent reports have demonstrated that PDPK1 can phosphorylate PKC isoforms. 33 Thus, we examined whether PDPK1 activates PKCd, thereby participating in K-Ras V12 -induced ROS generation. To this end, we examined whether PDPK1 is activated by K-Ras V12 . Importantly, the phosphorylation of PDPK1 was increased with expression of K-Ras V12 , indicating that the activity of PDPK1 depends on K-Ras V12 (Figure 6a ). Thus, we examined whether PDPK1 can phosphorylate PKCd in a K-Ras V12 -dependent manner. Importantly, kinase assays showed that PDPK1 phosphorylates wild-type PKCd but not the T505A mutant form (Figure 6b ). In agreement with these results, the T505A mutant form of PKCd showed a marked loss in affinity for p47 phox in the GST pull-down assay (Supplementary Figure  S4B) . In parallel, treatment with siRNA targeting PDPK1 inhibited K-Ras V12 -induced ROS generation and anchorageindependent colony formation (Figures 6c and d) . Furthermore, downregulation of PDPK1 suppressed PKCd phosphorylation and interaction with p47 phox , and decreased p47 phox translocation to the plasma membrane (Figure 6e ). These results indicate that PDPK1 participates directly in the K-Ras V12 -induced signaling axis for ROS generation. As p38 activated PKCd in K-Ras V12 -transduced cells, we tested whether p38 activates PKCd through PDPK1. To this end, we inhibited p38 activity by treatment with the specific p38 inhibitor, SB2003580, or transfection with DN-p38. Importantly, inhibition of p38 attenuated K-Ras V12 -induced phosphorylation of PDPK1 and reduced its kinase activity toward PKCd (Figure 6f ). In addition, immunoprecipitation showed that PDPK1 interacts with PKCd in a K-Ras V12 -dependent manner, an interaction that was abolished by inhibition of p38 (Figures 6f and g ). In contrast, treatment with the specific JNK inhibitor, SP600125 or ERK inhibitor PD98059, had no such effects (Supplementary Figure S4D) . Taken together, these results suggest that K-Ras V12 induces ROS generation and subsequent cellular transformation through activation of the p38/PDPK1/PKCd/p47 phox /NOX1 signaling axis.
K-Ras-driven signaling axis for ROS generation M-T Park et al
Endogenous oncogenic K-Ras promotes ROS generation in cancer cells, driving the same signaling pathway as an exogenous K-Ras V12 in normal fibroblasts. In the above data, when exogenous K-Ras V12 is introduced into normal fibroblasts, we observed that K-Ras V12 induces ROS generation by triggering the signaling cascade, p38/PDPK1/ PKCd/p47 phox /NOX1, consequently causing cellular transformation. We next examined whether the K-Ras-driven signaling cascade for ROS generation is also valid in cancer cells that have an oncogenic K-Ras mutation. To examine the possibility, we chose HCT116 and SW480 colon cancers that harbor the oncogenic mutant form of K-Ras.
Of importance, likely to the effect of K-Ras V12 in normal fibroblasts, siRNA-mediated downregulation of K-Ras caused to decrease the intracellular ROS in both cancer cell lines (Figure 7a ), indicating that endogenous oncogenic K-Ras contributes to ROS generation. We next examined whether the oncogenic K-Ras promotes ROS generation in cancer cells through the signaling cascade p38/PDPK1/ PKCd/p47 phox /NOX1 as in normal fibroblasts. Notably, downregulation of K-Ras inhibited the signaling components such as p38, PDPK1 and PKCd (Figure 7b ). In line with these results, treatment with an inhibitor specific to p38 decreased ROS generation in both cancer cells (Figure 7c) . Also, treatment with siRNA targeting either PDPK1 or p47 phox decreased the intracellular ROS in both cancer cell lines (Figure 7d; Supplementary Figure S4E ). Taken together, these results suggest that aberrant activation of K-Ras increases intracellular ROS in both cancer and normal fibroblasts through the signaling cascade, p38/PDPK1/ PKCd/p47 phox /NOX1.
Discussion
Many studies have suggested that K-Ras-induced ROS generation is responsible for cellular transformation. 11, 20, 21 In line with these studies, we observed that K-Ras V12 transforms normal fibroblasts in association with ROS generation, causing acquisition of anchorage-independent colony-forming ability and increased tumor-forming capacity.
In this study, we found that K-Ras V12 -induced ROS generation occurs through NOX1. For full activation, NOX1 requires the cytosolic regulatory subunit NOXO1 (NOX organizing protein-1) or, alternatively, the NOXO1 homolog p47 phox . Importantly, we found that K-Ras V12 promotes the activation of NOX1 through p47
phox . In addition, PKCd among PKC isozymes was selectively activated in a K-Ras-dependent manner. Notably, PKCd directly interacted with the tandem SH3-N domain of p47 phox and phosphorylated Ser348, -379 residues, promoting p47 phox translocation to the membrane fraction. The inactive form of p47 phox tends to adopt a closed form in which its two SH3 domains are masked through an intramolecular interaction with a polybasic/autoinhibitory region in the C terminus. 34 Activation and translocation of p47 phox to the membrane fraction requires phosphorylation of p47 phox at serine residues in the polybasic region/autoinhibitory region and PP domain, which induces a conformational change that leads to the exposure of two SH3 domains. 23 The exposed SH3 domains of p47 phox can directly interact with p22 phox , 23 allowing membrane translocation of p47 phox and activation of NADPH oxidase. In this study, we found that PKCd directly binds to the SH3-N domain of p47 phox in K-Ras V12 -expressing cells (Figure 4 ). It is likely that the direct binding of PKCd to the SH3-N domain in p47 phox increases the proximity and orientation of the active site in PKCd, facilitating its phosphorylation on Ser348, -379 in p47 phox . In agreement, DN-PKCd inhibited translocation of p47 phox to the plasma membrane and blocked K-Ras-induced ROS generation, anchorage-independent colony formation and tumor formation. Previously, PKCd has been reported to be implicated in the activation of NADPH oxidase in many cell lines. [35] [36] [37] However, the molecular mechanisms by which PKCd activates NADPH oxidase have not been elucidated. In this study, we report that PKCd directly binds to p47 phox and phosphorylates Ser348, -379, promoting its translocation to the membrane fraction and activation of NOX1.
PDPK1, known to have a key role in linking phosphoinositol 3-kinase (PI3K) to AKT, has been reported to be aberrantly overexpressed in breast cancers. 38, 39 Furthermore, it was recently suggested that PDPK1 activation is a critical contributor to carcinogenesis and tumor maintenance in oncogenic K-Ras-driven pancreatic cancer. 40 Consistent with these studies, we found that PDPK1 is activated in K-Ras V12 -expressing cells and contributes to oncogenic K-Ras-induced ROS generation and cellular transformation ( Figure 6 ). Conservation of amino-acid sequences similar to those surrounding Thr308 of AKT in the AGC family of Ser/Thr protein kinases suggests that PDPK1 might phosphorylate other protein kinases of the AGC family, including PKC isoforms. In agreement with this, recent reports have demonstrated that PDPK1 can phosphorylate PKC isoforms. 33 In this study, we found that PDPK1 binds and phosphorylates PKCd at Thr505 in a K-Ras-dependent manner ( Figure 6 ). In addition, downregulation of PDPK1 attenuated a K-Ras-induced interaction between PKCd and p47 phox and membrane translocation of p47 phox ( Figure 6 ). As PKCd interacts with PDPK1 as well as p47 phox , we suggest that PKCd, PDPK1 and p47 phox proteins may form a signal transduction complex that facilitates K-Rasinduced ROS generation as shown in the schematic model ( Figure 8 ).
Numerous studies have clearly shown that Ras induces activation of ERK, JNK and p38 MAPK signaling. 27, 41, 42 In line with these previous studies, we found that p38 is involved in K-Ras-induced ROS generation and malignant transformation. Inhibition of p38 blocked K-Ras-induced ROS generation, anchorage-independent colony formation and tumor formation. In parallel, overexpression of p38 increased ROS generation even in the absence of K-Ras V12 . Although inhibition of ERK blocked anchorage-independent colony formation, it did not affect ROS generation in K-Ras V12 -expressing cells, indicating that ERK might be involved in a ROS-independent pathway for K-Ras-induced malignant transformation. Extending our observation, we also found that, similarly to exogenous mutant K-Ras V12 in normal fibroblasts, endogenous oncogenic K-Ras in cancer cells induces ROS generation through the same signaling cascade.
Collectively, our data indicate that K-Ras V12 induces ROS generation via the signaling axis p38/PDPK1/PKCd/p47 phox / NOX1 in cancer cells as well as normal fibroblasts. In agreement with this conclusion, inhibition of either component in this signaling axis effectively abolished K-Ras V12 -induced ROS generation and cellular transformation. Our findings may provide new insight into the molecular mechanisms governing K-Ras V12 -induced cellular transformation and cancer progression.
Materials and Methods
Chemical reagents and antibodies. Monoclonal anti-K-Ras antibody was purchased from Oncogene Science (Cambridge, MA, USA). Polyclonal antibodies against PKCa, PKCb, PKCd, phospho-JNK, JNK, p38 MAPK and monoclonal antibodies against phospho-ERK1/2 and ERK were purchased from Santa Cruz (Santa Cruz, CA, USA). Polyclonal anti-b-actin antibody and monoclonal antibodies against Flag-Tag and GST were purchased from SigmaAldrich Co (St. Louis, MO, USA). Monoclonal antibodies against p47 phox and phospho-tyrosine were purchased from Upstate Biotechnology Inc. (Lake Placid, NY, USA). Polyclonal antibodies against phospho-p38 MAPK, phospho-PDPK1 (Ser 241), PDPK1, phospho-PKCd (Thr505), phospho-AKT (Thr 308), phospho-AKT (Ser 473), AKT1 and monoclonal antibodies against HA-Tag and ATF2 were purchased from Cell Signaling Technology (Beverly, MA, USA). Inhibitors specific to p38 MAPK (SB203580), PI3K/AKT (LY294002), JNK (SP600125) and MEK/ ERK (PD98059), and recombinant active PKCd, and monoclonal antibodies against phospho-serine and phospho-threonine were purchased from Calbiochem (San Diego, CA, USA). A monoclonal antibody against Rac1 was purchased from the BD Transduction Lab (San Jose, CA, USA).
Cell culture and siRNA transfection. Rat2 fibroblast cells were obtained from the American Type Culture Collection (Manassas, VA, USA) and were grown in RPMI 1640 medium (Gibco Invitrogen Corp, Paisley, UK) supplemented with 5% fetal bovine serum (FBS; Gibco Invitrogen Corp) and antibiotics at 37 1C in a humidified incubator with 5% CO 2 . All oligonucleotides and siRNAs were purchased from Ambion Inc. (Austin, TX, USA). siRNA duplexes were introduced into cells using Lipofectamine 2000 reagent (Gibco Invitrogen Corp).
Production of a retroviral vector containing the oncogenic K-Ras gene. To generate MFG-K-RasV12, PCR fragments produced against pSPORT-K-RasV12 as templates were cloned into the MFG retroviral vector derived from murine Moloney leukemia virus. For retrovirus production, a modified 293T cell line was cultured in DMEM (Gibco Invitrogen Corp) supplemented with 10% FBS, 2 mmol/l GlutaMAX (Gibco Invitrogen Corp), 50 units/ml penicillin/ streptomycin, 1 mg/ml tetracyclin, 2 mg/ml puromycin and 0.6 mg/ml G418 sulfate (Calbiochem) and transfected with MFG-K-RasV12 using the Lipofectamine 2000 reagent (Gibco Invitrogen Corp). At 48 h after the transfection, virus supernatant was harvested every day by replenishing with fresh medium for 5 days and passed through a 0.45-mm filter, and the viral supernatant was frozen at À 80 1C. The supernatant was used for infection after adding 4 mg/ml Polybrene (Sigma-Aldrich Co).
Western blot analysis. It was performed as described earlier. 43 Briefly, cell lysates were prepared by extracting proteins with lysis buffer (40 mM Tris-HCl (pH 8.0), 120 mM NaCl, 0.1% Nonidet-P40) supplemented with protease inhibitors. Proteins were separated by SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was blocked with 5% nonfat dry milk in Tris-buffered saline and incubated with primary antibodies for 1 h at room temperature. Blots were developed with peroxidase-conjugated secondary antibody, and proteins visualized by enhanced chemiluminescence (ECL; Amersham, Arlington Heights, IL, USA), following the manufacturer's recommendations.
Immunoprecipitation. Solubilized extracts (100-500 mg) in lysis buffer were precleared with protein A-Sepharose (Sigma-Aldrich Co), and the resulting supernatant fractions were incubated with a primary antibody (2 mg/ml) at 4 1C for 4 h. Immunoprecipitates were collected by incubating with protein A-Sepharose for 1 h, followed by centrifugation for 2 min at 4 1C. Pellets were washed five times with lysis buffer. Immunoprecipitates dissolved in SDS sample buffer were analyzed by western blotting, as described above.
Immune complex kinase assay. Proteins from 300 mg of cell extracts were immunoprecipitated with a primary antibody (2 mg/ml) at 4 1C for 4 h. Immunoprecipitates were washed twice with kinase reaction buffer (50 mM HEPES (pH 7.5), 10 mM MgCl2, 1 mM dithiothreitol, 2.5 mM EGTA, 1 mM NaF, 0.1 mM Na3VO4 and 10 mM glycerophosphate) and resuspended in 20 ml of kinase reaction buffer. The kinase assay was initiated by adding 20 ml of kinase reaction buffer, containing 10 mg of substrate and 2 mCi of [32P]ATP (ICN). Reactions were performed at 30 1C for 30 min, and terminated by adding SDS sample buffer. Mixtures were boiled for 5 min. The reaction products were analyzed by SDS-PAGE and autoradiography.
Clonogenic survival assay in soft agar. Rat2 fibroblast cells (1 Â 10 4 cells) were suspended in 2 ml of 0.3% Difco Noble agar (Difco, Detroit, MI, USA) supplemented with complete culture medium. This suspension was layered over 2 ml of 0.8% agar medium base layer in 60-mm dishes and followed by incubation for 14 days at 37 1C in 5% CO2 incubator. Before counting colonies, the culture medium was decanted and the cells were fixed in 95% methanol and stained with 0.5% crystal violet. The numbers of colonies (450 cells) from triplicate dishes were counted. Mean colony numbers relative to control colony numbers were plotted.
Tumor formation in xenograft mice. Rat2 fibroblast cells (1 Â 10 7 cells) were trypsinized, washed with PBS and suspended in 100 ml PBS. A 100 ml of cell suspension was injected subcutaneously into each nude mouse (BALB/c, male). The growth of these tumors was monitored by two-day intervals, and growth rates were determined using caliper measurements. 
